A Study of Oncolytic Virus Injection (RT-01) in Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov ID NCT05205421
Sponsor First Affiliated Hospital Bengbu Medical College
Information provided by Wang Zishu, First Affiliated Hospital Bengbu Medical College (Responsible Party)
Last Update Posted
2022-08-05
Study Overview
Brief Summary
This is a single-arm, open-label, clinical pharmacology study to evaluate safety and efficacy of oncolytic virus injection(RT-01) in Patients With Extensive-Stage Small Cell Lung Cancer.
The purpose of this study is to evaluate the safety and tolerability, antitumor activity, The immunoreactivity, The immunogenicity, pharmacokinetics and virus shedding of RT-01.